创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

HOU Jingjing, GONG Hui, ZHAO Yichang, XU Ping, ZHANG Bikui, YAN Miao. Prevention and Treatment of Adverse Drug Reactions in COVID-19[J]. Progress in Pharmaceutical Sciences, 2020, 44(2): 153-158.
Citation: HOU Jingjing, GONG Hui, ZHAO Yichang, XU Ping, ZHANG Bikui, YAN Miao. Prevention and Treatment of Adverse Drug Reactions in COVID-19[J]. Progress in Pharmaceutical Sciences, 2020, 44(2): 153-158.

Prevention and Treatment of Adverse Drug Reactions in COVID-19

  • Based on the medication regimens recommended by Diagnosis and Treatment Scheme for COVID-19 (Trial Version 6.0), including antiviral drugs, corticosteroids and traditional Chinese medicines, this article reviews the possible adverse reactions and their prevention and treatment strategy during the treatment of COVID-19 in terms of the mechanisms of action, drug interactions and adverse drug reactions, aiming to provide reference for the selection of reasonable therapeutic regimens.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return